<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kodali, Susheel K.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">TAVR Associated with Increased Late Mortality from Paravalvular Regurgitation</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-13</style></pages><abstract><style  face="normal" font="default" size="100%">One-year data from the Placement of Aortic Transcatheter Valves Trial [PARTNER; NCT00530894] showed that survival rates were similar among high-risk patients with aortic stenosis who received either transcatheter aortic valve replacement or surgical replacement [Smith CR et al. N Engl J Med 2011; Vinall M. MD Conference Express: ACC 2011]. This article discusses outcomes after 2 years of follow-up in the PARTNER trial [Kodali SK et al. N Engl J Med 2012].</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>